The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients
Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…Identifying Incident Cases of Neurodegenerative Parkinsonism in a Large Observational At-Risk Cohort: the PPMI study
Objective: To examine the potential of a data-driven approach to identify incident cases of neurodegenerative parkinsonian disorders (PD) in a large observational cohort of individuals…Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects
Objective: To establish whether home-based computerized attentional training would improve cognition, gait, and function in Parkinson’s disease (PD). Background: Impairments in cognition and gait are…Parkinson’s disease and melanoma: a serie of 33 patients
Objective: The objective of our work was to characterize the clinical features of patients with malignant melanoma (MM) associated with Parkinson’s disease (PD) and to…Modifiable factors and progression of motor symptoms and cognitive decline in Parkinson’s disease
Objective: To determine the association between potentially modifiable factors including (1) cardiovascular risk factors (2) neuropsychiatric symptoms, and (3) sleep quality and progression of motor…Effect of Levodopa on gut microbiome in Parkinson’s Disease (PD)
Objective: To characterize changes in the gut microbiome in de novo PD subjects before and after initiating carbidopa/levodopa Background: The gastrointestinal microbiome in patients with…Parkinson’s disease polygenic risk score is not associated with impulse control disorders: a longitudinal study
Objective: To examine the relationship between a polygenic risk score (GRS) associated with Parkinson’s disease (PD) and impulse control disorders (ICDs) in PD. Background: Genome…No difference in balance and gait parameters of the patients with akinetic-rigid and tremor-dominant Parkinson’s disease
Objective: To compare balance and gait parameters between subtypes of Parkinson's disease (PD). Background: PD, which is a progressive neurodegenerative disease, has different clinical courses…Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study
Objective: To determine whether there are longitudinal differences in serum uric acid level among sporadic Parkinson’s disease (PD) patients, PD patients harboring the p.A53T mutation…Patients Experiencing Motor Fluctuations With Parkinson’s Disease (PD): Participant Characteristics in the Accordance Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa
Objective: To provide baseline and clinical characteristics for participants in the phase 3 Accordance study of the Accordion Pill™ (AP)—a gastric-retentive formulation of carbidopa/levodopa (CD/LD)—versus…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.